Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
by
Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ.
Neuropharmacology, Zoological Institute
J Neural Transm. 2003 Jul;110(7):707-18

ABSTRACT

3,4-Methylenedioxymethamphetamine (MDMA) has recently been hypothesized to be effective against the symptoms of Parkinson's disease. Therefore we tested the effects of MDMA-derivatives in the rotational behavioural model. Male Sprague Dawley rats were lesioned unilaterally with 6-hydroxydopamine at the medial forebrain bundle. MDMA was administered at doses of 2.5, 5.0 and 10.0 mg/kg, its derivatives N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butananamine (MBDB), 3,4-Methylenedioxy-N-ethylamphetamine (MDE) and 3,4-Methylenedioxyamphetamine (MDA) at 5.0 mg/kg respectively. All substances induced ipsilateral rotations, MDA being the most effective. MDMA induced rotations were attenuated by the selective serotonin reuptake inhibitor Citalopram but were only slightly reduced by pre-treatment with the selective serotonin synthesis inhibitor PCPA (para-chlorophenylalanine). The effects of MDMA can therefore not fully be explained by serotonin release or by dopaminergic activity of the drugs.

Vanoxerine
MDMA/MDE
Controversies
Protect and survive
MDMA and immunity
MDMA and dopamine
Dopaminergic damage
MDMA and serotonin synthesis
MDMA, serotonin and dopamine
Ecstasy and Parkinson's disease

Refs
HOME
HedWeb
BLTC Research
The Good Drug Guide
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
Critique of Huxley's Brave New World